The Family Firm’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-841
Closed -$66.2K 590
2024
Q2
$66.2K Buy
+841
New +$68.9K 0.01% 349
2016
Q4
Sell
-2,803
Closed -$242K 112
2016
Q3
$242K Buy
2,803
+200
+8% +$17.4K 0.12% 101
2016
Q2
$226K Buy
+2,603
New +$210K 0.11% 95
2016
Q1
Sell
-2,798
Closed -$215K 110
2015
Q4
$215K Buy
+2,798
New +$211K 0.11% 97
2015
Q3
Sell
-3,056
Closed -$226K 109
2015
Q2
$226K Sell
3,056
-133
-4% -$10.2K 0.12% 93
2015
Q1
$249K Buy
+3,189
New +$242K 0.13% 88

Other funds holding MDT

The Family Firm's MDT Position: Q3 2024 in Review

The Family Firm sold out of Medtronic (MDT) in Q3 2024, closing a stake of 841 shares — an estimated $66.2K sold.

The Family Firm first reported a position in MDT in Q1 2015 and held it in 6 quarters. The position peaked at $249K in Q1 2015. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • The Family Firm reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • The Family Firm sold 841 Medtronic shares in Q3 2024, an estimated $66.2K.
  • The Family Firm first reported a position in Medtronic in Q1 2015 and held it in 6 quarters.
  • The Family Firm's Medtronic position peaked at $249K in Q1 2015.
  • 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.